Researchers at BYU have devised a system to speed up the process of making life-saving vaccines for new viruses.
Their concept is to create the biological machinery for vaccine production en masse, put it in a freeze-dried state and stockpile it around the country. Then, when a new virus hits, labs can simply add water to a “kit” to rapidly produce vaccines.
“You could just pull it off the shelf and make it,” said senior author Brad Bundy, associate professor of chemical engineering. “We could make the vaccine and be ready for distribution in a day.”
The research, published in Biotechnology Journal, demonstrates the ability to store the drug and vaccine-making machinery for more than a year.
Traditional systems to produce vaccines for pandemic influenza strains require heavy engineering and specialized equipment that only a few labs across the country have on hand. These traditional systems are also time-consuming, taking months to execute.
Bundy’s idea is a new angle on the emerging method of “cell-free protein synthesis,” a process that combines DNA to make proteins needed for drugs (instead of growing protein in a cell). His lab is creating a system where the majority of the work is done beforehand so vaccine kits can be ready to go and be activated at the drop of a dime.
“It will not only provide a quicker response to pandemics, but it will also make protein-based drugs more available to third-world countries where production and refrigerated storage can be problematic,” added William Pitt, a study coauthor and fellow BYU professor of chemical engineering.
While the team is now testing their version of the cell-free, recombinant DNA process for vaccine production, they’ve already successfully demonstrated it for at least one anti-cancer protein (onconase).
The researchers believe their method can significantly reduce investment of time and money towards future drug production and, in turn, reduce treatment expenses for patients.
“The drugs today are changing,” Bundy said. “The lifesaving cancer drugs we have now, the drugs for arthritis, the drugs with the greatest impact, are made out of proteins, not small chemical molecules. This method takes full advantage of that to provide a quicker, more personal response.”
The Latest on: Making vaccines
via Google News
The Latest on: Making vaccines
- Hepatitis A Vaccine Market Research and Global Briefing Report 2020 to 2026on January 24, 2020 at 10:49 pm
Global Hepatitis A Vaccine Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product ...
- Drugmakers chase vaccine as coronavirus spreads globallyon January 24, 2020 at 5:25 pm
Drugmakers are hustling to make a vaccine to counter the rapidly-spreading respiratory virus that has sickened at least 830 in China and two people in the United States. The National Institutes of ...
- Two local labs working on developing coronavirus vaccineon January 24, 2020 at 3:21 pm
Coronavirus outbreak: 2nd US case confirmed in Chicago Right away, Inovio, along with researchers at the Wistar Institute and two other teams, started working on a vaccine using new, faster technology ...
- Different outbreak, same strategy: Inside Novavax's plans for a China coronavirus vaccineon January 24, 2020 at 2:32 pm
Novavax's China coronavirus vaccine development should come as no surprise — the Gaithersburg biotech made similar moves for Zika, Ebola and swine flu. But what's the end game this time?
- With Wuhan virus genetic code in hand, scientists begin work on a vaccineon January 24, 2020 at 1:59 pm
When a newly organized vaccine research group at the U.S. National Institutes of Health (NIH) met for the first time this week, its members had expected to be able to ease into their work. But their ...
- Life science companies make first moves to attack deadly coronaviruson January 24, 2020 at 1:51 pm
Bay Area biotech companies are among those taking the first steps toward developing treatments or vaccines for the deadly Wuhan coronavirus that has killed at lest 25 of the more than 800 people ...
- Novavax exec: Making a coronavirus vaccine could take a long timeon January 24, 2020 at 1:18 pm
The coronavirus that has killed dozens and rattled markets has no immediate cure — and a vaccine could be years in the making, a medical executive told Yahoo Finance. The Chinese Health Commission ...
- Drugmakers rushing to make vaccine for Chinese coronaviruson January 24, 2020 at 1:05 pm
Drugmakers are working to quickly develop a vaccine to combat the novel respiratory infection originating in Wuhan, China, that's killed 26 people, The Wall Street Journal reported. Moderna ...
- How fast can biotech come up with a vaccine for the latest outbreak?on January 24, 2020 at 12:10 pm
The Zika outbreak dissipated in 2016, sapping the need for a vaccine and making it virtually impossible to run the large-scale trials necessary to prove one’s worth. Good news for the world can be bad ...
- Meningococcal Vaccines Market Value will Touch $9.37 Bn by 2026on January 24, 2020 at 4:15 am
According to Acumen Research, the global Meningococcal Vaccines Market is expected to surpass US$ 9.37 Bn by 2026, increasing at a CAGR of 12.3% between 2019 and 2026. The report provides analysis of ...
via Bing News